Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 29, 2015 7:29 AM ET

Capital Markets

Company Overview of Baker-Tisch Investments

Executive Profile

Julian C. Baker

Managing Partner, Lead Independent Director and Chairman of Nominating & Corporate Governance Committee, Genomic Health Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 6 different industries.

See Board Relationships


Mr. Julian C. Baker, also known as Jim, has been Executive Director of Market Development at Idera Pharmaceuticals, Inc. since January 2015. Mr. Baker serves as Managing Partner at Genomic Health Inc. Mr. Baker served as Executive Director of Corporate Affairs at Idera Pharmaceuticals, Inc. until January 2015. He served as a Managing Partner of Baker Brothers Investments. Mr. Baker co-founded Baker Brothers Investments in 2000. He is a Managing Partner of Baker-Tisch ...

Corporate Headquarters

667 Madison Avenue
New York, New York 10065

United States

Phone: 212-521-2245
Fax: --

Board Members Memberships

Board Member
Former Director
Independent Director, Chairman of Compensation Committee and Member of Corporate Governance Committee
Vice Chairman, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Finance Committee
Managing Partner, Lead Independent Director and Chairman of Nominating & Corporate Governance Committee
Director, Member of Nomination & Governance Committee and Member of Compensation Committee
Executive Director of Market Development and Director


Harvard University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$12,500
Total Calculated Compensation$215,984

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
Percy C. Tomlinson Jr.Chief Executive Officer, President and Director
Alliance Healthcare Services, Inc.
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
Michael J. Pellini M.D., MBAChief Executive Officer and Director
Foundation Medicine, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Baker-Tisch Investments, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at